IP Library Granted Patent US 9,718,858
Granted Patent B2
US 9,718,858 · App. 14/773,937 · Granted Aug 1, 2017

Tunable control of protein degradation in synthetic and endogenous bacterial systems

Inventors: Douglas Ewen Cameron (Boston, MA); James J. Collins (Newton Centre, MA)
Assignee: TRUSTEES OF BOSTON UNIVERSITY
C07K5/0823C07K5/0806C07K5/0812C07K5/0817C07K5/0819C07K5/101C07K5/1016C07K5/1019C07K5/1024C07K7/06C07K14/30G01N33/502C07K2319/95G01N2333/30G01N2500/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,718,858
App. No.
14/773,937
Granted
Aug 1, 2017
Kind
B2
Abstract

The methods and compositions described herein relate, in part, to the generation of a synthetic degradation system in E. coli that provides tunable control of the protein level of targeted genes by using components of the Mesoplasma florum tmRNA system. Provided herein are degradation tag variants that permit independent control of both the initial level and inducible degradation rate of attached proteins.

Claims (13)

1. A composition comprising:

a modified Mesoplasma florum ssrA protein degradation tag or a polynucleotide construct encoding the same;

wherein the modified degradation tag is degraded by Mesoplasma florum Lon protease at a higher rate compared to the unmodified Mesoplasma florum ssrA degradation tag,

wherein the modified protein degradation tag is not degraded by ClpXP, an E. coli Lon protease, or an Lactococcus lactis protease, and

wherein the modified protein degradation tag comprises one or more substitutions of amino acid residues corresponding to amino acids 24-27 of SEQ ID NO: 1.

2. The composition of claim 1 , wherein the substitutions comprise one or more arginine and/or glutamine residues.

3. The composition of claim 1 , wherein the modified degradation tag has an amino acid sequence in place of residues 24 to 27 of SEQ ID NO: 1 selected from: RLQL (SEQ ID NO: 30), ICRL (SEQ ID NO: 35), YLSQ (SEQ ID NO: 31), YQYR (SEQ ID NO: 116), RRRV (SEQ ID NO: 117), HISP (SEQ ID NO: 118), RICR (SEQ ID NO: 119), HAQP (SEQ ID NO: 120), RARQ (SEQ ID NO: 121), VVRR (SEQ ID NO: 122), RAQQ (SEQ ID NO: 123), RRQL (SEQ ID NO: 124), and QRQRQ (SEQ ID NO: 125).

4. The composition of claim 1 , wherein the modified degradation tag is fused to a target protein.

5. The composition of claim 4 , wherein the modified degradation tag is expressed in a bacterial cell.

6. The composition of claim 5 , wherein the bacterial cell is E. coli.

7. The composition of claim 5 , wherein the bacterial cell is Lactococcus lactis.

8. The composition of claim 1 , wherein the composition is a DNA vector comprising a multiple cloning site positioned for creation of a fusion protein with the modified degradation tag.

9. The composition of claim 8 , wherein the DNA vector comprises one or more regulatory elements for expression of the fusion protein in bacterial cells.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jun 23, 2016
From: BOSTON UNIVERSITY CHARLES RIVER CAMPUS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039121/0109 →
Continuity (2)
Provisional Application 61779547 · Mar 13, 2013
Related Publication 20160016995A1 · Jan 21, 2016